Ion Mobility LC-MS Metabolomics | CCS-Assisted Identification

Q: Is ion mobility metabolomics suitable for drug metabolism and natural product research?

Yes. Drug metabolism studies benefit from resolving phase-I and phase-II metabolite isomers, while natural product discovery depends on distinguishing structurally related secondary metabolites where isomer identity determines bioactivity.

Ion Mobility Metabolomics — What It Adds to LC-MS

Standard untargeted LC-MS identifies features by accurate mass and retention time, then confirms them by MS/MS fragmentation. Two limitations persist: isomeric compounds that share the same mass and formula, and isobaric compounds with nearly identical mass, often co-elute and produce indistinguishable spectra. Ion mobility adds a gas-phase separation step that resolves these ions by their collision cross section (CCS) — a physical property tied to ion shape and size — before mass analysis.

CCS gives untargeted data a fourth, orthogonal dimension. Because CCS is largely independent of chromatographic system and matrix, it provides reproducible, instrument-transferable evidence that mass and retention time alone cannot. Two metabolites with near-identical MS/MS spectra can be separated and correctly assigned by their distinct CCS values, and a measured CCS can reject candidate structures whose predicted CCS falls outside a narrow tolerance window.

Ion mobility metabolomics delivers:

Isomer and isobar separation: baseline resolution of compounds that co-elute and share mass, including lipid and glycan isomers
CCS as identification evidence: a measured, instrument-transferable value added to every feature alongside m/z, RT, and MS/MS
Higher annotation confidence: CCS filtering removes false candidate structures and upgrades identifications that mass accuracy alone cannot confirm

Conventional LC-MS vs. Ion Mobility LC-MS Metabolomics

Dimension	Conventional LC-MS	Ion Mobility LC-MS
Identification dimensions	Three: m/z, retention time, MS/MS	Four: m/z, RT, MS/MS, and CCS
Isomer resolution	Isomers and isobars often co-elute; mass and spectra alone cannot separate them	Gas-phase separation resolves isomers and isobars by shape and size before detection
False-positive control	Candidate structures filtered only by mass and MS/MS match	CCS tolerance window rejects candidate structures with mismatched ion size
Data transferability	Retention time varies between systems and laboratories	CCS is instrument-transferable, comparable across platforms and published libraries

When Ion Mobility Matters — Isomers, Isobars, and Where CCS Helps

Not every untargeted study needs ion mobility. The technology pays off most when your feature set is dominated by compound classes where isomerism is the rule rather than the exception:

Lipids and lipid-like molecules — glycerophospholipids, triacylglycerols, and sphingolipids differ by sn-position and double-bond location; CCS resolves isobaric and isomeric lipid species that dominate lipidomics
Carbohydrates and glycans — hexose isomers (glucose vs. fructose vs. galactose) and glycan linkage isomers share exact mass and are difficult to separate chromatographically
Amino acid and small-molecule isomers — leucine vs. isoleucine, and positional isomers of organic acids, resolve by their gas-phase conformations
Natural products and xenobiotics — structurally diverse secondary metabolites where isomer identity determines biological activity
Exposomics and drug metabolites — co-eluting matrix interferences and phase-II metabolite isomers benefit from the added separation dimension

Ion Mobility LC-MS Platform and Technical Parameters

We run ion mobility metabolomics on a trapped ion mobility (TIMS) platform — the most widely adopted ion mobility technology in metabolomics research — coupled to high-resolution mass analysis. TIMS accumulates and releases ions by their gas-phase mobility before MS/MS, giving an extra separation dimension without sacrificing throughput.

Parameter	Specification
Ion mobility platform	Trapped ion mobility spectrometry (TIMS) coupled to high-resolution Q-TOF mass analysis
CCS measurement	Collision cross section (CCS, Å²) measured for each detected feature; calibration against a known CCS reference set per batch
CCS reproducibility	Inter-batch CCS RSD typically below 1 percent; instrument-transferable values for database matching
Four-dimension acquisition	m/z, retention time, ion mobility (1/K0), and MS/MS fragment spectra acquired in a single run per sample
Isomer resolution	Gas-phase separation of isobaric and isomeric species that co-elute chromatographically
Mass accuracy	Low-ppm high-resolution mass measurement with internal lock-mass correction

Bruker timsTOF trapped ion mobility mass spectrometer

Trapped Ion Mobility (TIMS)

Gas-phase ion mobility separation with CCS measurement

Ion Mobility Metabolomics Workflow — A Step-by-Step Guide

Study Design and Sample Preparation

We define the sample set, matrix-specific extraction, and pooled QC design with you. Samples are extracted under controlled conditions with internal standards spiked at extraction.

Trapped Ion Mobility LC-MS Acquisition

Each sample is analyzed by LC-IM-MS in a single run that captures m/z, retention time, ion mobility, and MS/MS spectra simultaneously. CCS calibration references are acquired in every batch.

Feature Detection and CCS Calculation

Features are detected with deisotoping and adduct deconvolution; CCS values are calculated from measured ion mobility against the calibration set and appended to every feature.

CCS-Assisted Annotation

Features are matched against spectral and CCS libraries; measured CCS filters candidate structures within a narrow tolerance window, rejecting false assignments that mass accuracy alone cannot exclude.

Data Delivery and Interpretation Support

The data package includes CCS-annotated feature tables, ion mobility drift plots, QC metrics, raw IM-MS data, and a methods appendix for reproducible downstream analysis.

CCS-Assisted Metabolite Annotation

Conventional annotation ranks candidate structures by accurate mass and MS/MS spectral similarity. CCS adds an independent filter: a candidate is accepted only if its measured CCS matches the predicted or library CCS within a tight tolerance. This single orthogonal constraint removes a large fraction of false candidates that would otherwise rank highly.

Library CCS matching — measured CCS values are searched against curated metabolite CCS libraries for direct annotation
Predicted CCS filtering — in silico CCS prediction scores candidate structures from in silico fragmentation tools, narrowing the candidate list
Isomer disambiguation — isomeric candidates that share mass and near-identical spectra are separated by their distinct CCS values
Instrument-transferable evidence — CCS values are reproducible across instruments and laboratories, so annotations travel with the data

Ion mobility drift plot showing baseline-separated isomeric species with CCS values

Representative ion mobility plot: isomeric species resolved by CCS with drift time and CCS values annotated.

CCS versus m/z scatter plot showing isomeric pairs separated in the CCS dimension

CCS vs m/z scatter plot: isomer pairs sharing m/z resolved as distinct CCS values across the metabolome.

CCS Library and Calibration

CCS annotation is only as good as the library and calibration behind it. We maintain a curated metabolite CCS library and calibrate every batch against a reference CCS set, so measured values are directly comparable to published databases.

Attribute	Description
CCS library coverage	Curated metabolite CCS library covering major metabolite and lipid classes; supplemented by public CCS databases for broad matching
CCS calibration	Batch-level calibration against a known CCS reference set spanning the mobility range of the analytes
CCS tolerance window	Candidate matching within a defined CCS tolerance (typically ±1–3 percent, study-dependent)
CCS reproducibility QC	Inter-batch CCS RSD tracked in every report to confirm value transferability

Metabolite Identification Confidence Levels

We report identifications using the established confidence levels, and CCS upgrades assignments that mass accuracy alone cannot confirm.

Confidence Level	Criteria	CCS Contribution
Level 1	Confirmed by authentic reference standard (RT, MS/MS, and CCS match)	CCS adds an independent confirmation dimension
Level 2	Putatively annotated by library MS/MS and CCS match	CCS rejects isomeric alternatives with distinct CCS values
Level 3	Candidate class or structure assigned by predicted CCS and in silico fragmentation	Predicted CCS narrows the candidate space
Level 4	Unknown feature with measured m/z, RT, and CCS (no confident assignment)	CCS recorded for future database re-annotation

Why Choose Our Ion Mobility Metabolomics Service

Four-Dimension Identification
m/z, RT, MS/MS, and CCS acquired in one run — more evidence per feature than conventional LC-MS.
Isomer and Isobar Resolution
Gas-phase separation resolves species that co-elute and share mass, a capability conventional LC-MS lacks.
Curated CCS Library and Calibration
Batch-level CCS calibration and a curated metabolite library make measured values directly comparable to published data.
Instrument-Transferable Evidence
CCS values are reproducible across instruments and laboratories, so your annotations stay valid beyond a single run.
Confidence-Level Reporting
Every feature is reported with its identification confidence level, so you know exactly how each assignment was made.
Collaborator-Ready Deliverables
CCS-annotated tables, drift plots, QC metrics, and a methods appendix support clear communication to collaborators and reviewers.

Ion Mobility Metabolomics Sample Requirements

Sample Type	Minimum Amount	Preparation	Storage and Shipping
Plasma / Serum	≥ 50 µL	Collect in EDTA tube, centrifuge at 4°C, aliquot, avoid hemolysis	−80°C; ship on dry ice
Tissue	≥ 20 mg wet weight	Snap-freeze in liquid nitrogen; record wet weight	−80°C; ship on dry ice
Cells	≥ 1 × 10⁶ cells	Wash with cold PBS, centrifuge at 4°C, snap-freeze pellet	−80°C; ship on dry ice
Urine / CSF	≥ 100 µL	Aliquot immediately; minimize freeze-thaw cycles	−80°C; ship on dry ice
Plant / Fermentation Extract	≥ 200 mg / 200 µL	Homogenize; record processing history	−20°C or −80°C; ship on dry ice

Critical Notes:

Untargeted discovery requires consistent sample handling — pooled QC samples are strongly recommended so CCS and intensity drift can be corrected across the batch.
For lipid-focused studies, minimize freeze-thaw cycles which can alter isomeric lipid composition.

Ion Mobility Metabolomics Data Deliverables

CCS-Annotated Feature Table (.xlsx/.csv)
m/z, retention time, CCS (Å²), MS/MS match score, annotation confidence level, and QC flags per feature.

QA/QC Report
CCS calibration, CCS reproducibility RSD, internal standard recovery, pooled QC trend plots.

Ion Mobility Plots
Drift-time and CCS distributions with isomer pairs highlighted; feature-level mobilograms.

Raw IM-MS Data
Vendor-native and open formats (.mzML) for downstream re-analysis.

Methods Appendix
IM platform settings, CCS calibration details, annotation workflow — formatted for reproducible reporting.

Ion Mobility Metabolomics Applications

Ion mobility metabolomics supports researchers where isomer identity and annotation confidence determine the outcome:

Drug Metabolism and Pharmacometabolomics — resolve phase-I and phase-II metabolite isomers and confirm drug metabolite structures
Lipidomics and Metabolic Disease — resolve isobaric and isomeric lipid species for cardiovascular and metabolic research
Natural Product Discovery — distinguish structurally related secondary metabolites where isomer identity drives bioactivity
Exposomics and Environmental Toxicology — separate co-eluting matrix interferences and assign pollutant-derived features with higher confidence
Glycomics and Carbohydrate Metabolism — resolve hexose and glycan linkage isomers that share exact mass

For discovery-scale screening that feeds into this workflow, our untargeted metabolomics service provides the conventional LC-MS foundation; ion mobility adds the CCS dimension. Where candidate structures remain unresolved, our unknown metabolite identification service extends the annotation. For downstream interpretation, our metabolomics data analysis team supports pathway and statistical reporting.

Case Study: Multi-Omics Identifies Xanthine as a Pro-Survival Metabolite in Mitochondrial Dysfunction

Multi-omics identify xanthine as a pro-survival metabolite for nematodes with mitochondrial dysfunction

Gioran, A., Piazzesi, A., Bertan, F., Schroer, J., Wischhof, L., Nicotera, P., and Bano, D. | The EMBO Journal, 2019, 38(6)

DOI: 10.15252/embj.201899558

Background

Mitochondrial dysfunction triggers broad metabolic rewiring, yet which metabolites actively support survival under bioenergetic stress is difficult to resolve from bulk readouts alone. This study asked whether specific metabolites confer pro-survival effects in nematode models of mitochondrial dysfunction.

Challenge: Identify the metabolic signatures distinguishing long-lived mutants under mitochondrial dysfunction from controls, and pinpoint which metabolites drive the survival phenotype.

Analytical Approach

Multi-omics profiling — including UPLC-MS lipidomics performed at Creative Proteomics — was applied to wild-type, age-1, gas-1, and age-1;gas-1 mutant nematodes, with all profiles normalized to nematode number per sample. The integrated analysis identified xanthine as a metabolite whose abundance tracked the pro-survival phenotype.

Key Findings

Metric	Finding
Pro-survival metabolite	Xanthine identified by multi-omics integration as elevated in the pro-survival context
Metabolic profiling	UPLC-MS lipidomics across four genotypes, normalized per sample
Mitochondrial context	Metabolite signatures resolved under mitochondrial dysfunction in C. elegans models
Integrated readout	Multi-omics analysis linked metabolite abundance to the survival phenotype

What This Means for Your Ion Mobility Metabolomics Research

Metabolite identification drives mechanism. Pinpointing xanthine as the pro-survival metabolite required confident identification across a complex background. Ion mobility adds the CCS dimension to this workflow, so isomeric and isobaric candidates are resolved rather than summed into one feature.
Isomer resolution matters for annotation. Purine-related metabolites share mass and fragmentation patterns; CCS-assisted annotation assigns each with higher confidence than mass accuracy alone.
Multi-omics integration benefits from orthogonal evidence. A measured CCS provides instrument-transferable identification evidence that strengthens cross-platform multi-omics conclusions.

Conclusion

This study shows how confident metabolite identification can reveal the molecules behind a phenotype. Our ion mobility LC-MS metabolomics service extends this capability with CCS-assisted annotation — resolving the isomeric and isobaric species that conventional LC-MS sums together, for higher-confidence identification in your own studies.

What is ion mobility LC-MS and how does it differ from conventional LC-MS?

Ion mobility adds a gas-phase separation step between liquid chromatography and mass analysis. Ions are separated by their collision cross section (CCS) — a measure of their size and shape in the gas phase — before mass detection. Conventional LC-MS separates only by chromatography and mass; ion mobility adds a third separation dimension that resolves isomeric and isobaric compounds that co-elute and share mass.

What is collision cross section (CCS) and why does it improve identification?

CCS is a physical property of an ion related to its gas-phase shape and size, measured in square angstroms (Å²). Because CCS is largely independent of the chromatographic system and matrix, it provides orthogonal, instrument-transferable evidence for identification. A measured CCS can confirm a candidate whose mass and MS/MS match are ambiguous, and can reject candidates whose predicted CCS falls outside a narrow tolerance window.

Which ion mobility technology do you use?

We use trapped ion mobility spectrometry (TIMS) coupled to high-resolution Q-TOF mass analysis. TIMS is the most widely adopted ion mobility technology in metabolomics, and it acquires m/z, retention time, ion mobility, and MS/MS spectra in a single run per sample.

Can ion mobility separate isomers that conventional LC-MS cannot?

Yes. Isomeric compounds share the same formula and mass, and often co-elute chromatographically with near-identical MS/MS spectra. Ion mobility separates them by gas-phase shape, so isomeric lipids (differing in sn-position or double-bond location), hexose isomers, and amino acid isomers can be resolved and assigned distinct CCS values.

What is your CCS library coverage for metabolites?

We maintain a curated metabolite CCS library covering major metabolite and lipid classes, supplemented by public CCS databases for broader matching. Coverage spans lipids, amino acids, carbohydrates, organic acids, and natural products. Exact coverage for your analyte classes is confirmed during study design.

How is CCS calibration and reproducibility maintained?

Every batch is calibrated against a known CCS reference set spanning the mobility range of the analytes. Inter-batch CCS reproducibility is tracked as RSD, typically below 1 percent, and reported in the QC summary. This calibration makes measured values directly comparable to published CCS databases.

What sample types and minimum input do you accept?

We accept plasma, serum, tissue, cells, urine, CSF, plant extracts, and fermentation broth. Minimum input is approximately 50 µL for plasma or serum, 20 mg for tissue, 1 × 10⁶ cells, and 200 mg or 200 µL for plant or fermentation extracts. Exact requirements are confirmed during study design.

Can ion mobility metabolomics be combined with standard untargeted workflows?

Yes. Ion mobility is an upgrade to the standard untargeted LC-MS workflow, not a replacement. The same sample can be profiled with both conventional LC-MS (for broader coverage) and ion mobility LC-MS (for isomer resolution and CCS evidence), giving you complementary datasets from one submission.

How are CCS values reported in deliverables?

Every feature in the data table is reported with its measured CCS (Å²) alongside m/z, retention time, MS/MS match score, and identification confidence level. Ion mobility drift plots are also included, with isomer pairs highlighted where relevant.

Is ion mobility metabolomics suitable for drug metabolism and natural product research?

Yes — these are two of the strongest applications. Drug metabolism studies benefit from resolving phase-I and phase-II metabolite isomers, while natural product discovery depends on distinguishing structurally related secondary metabolites where isomer identity determines bioactivity.

Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia by disrupting glycerophospholipid metabolism

Gonzalez, M. A., Olivas, I. M., Bencomo-Alvarez, A. E., et al.

Journal: Clinical and Translational Medicine, 2022, 12(12)

LC/MS-based lipidomics performed at Creative Proteomics resolved glycerophospholipid remodeling in CML, linking lipid metabolism disruption to disease progression and drug resistance. Demonstrates lipidomics workflows where isomer-resolving power adds confidence.

The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease

Brakedal, B., Dölle, C., Riemer, F., et al.

Journal: Cell Metabolism, 2022, 34(3), 396–407.e6

Untargeted metabolomics applied to a clinical trial cohort, linking NAD precursor supplementation to brain NAD levels and metabolic changes. Demonstrates untargeted profiling for intervention studies.

Dimethyl fumarate treatment restrains the antioxidative capacity of T cells to control autoimmunity

Liebmann, M., Korn, L., et al.

Journal: Brain, 2021, 144(10), 3126–3141

Untargeted metabolomics of T cells under dimethyl fumarate treatment, revealing metabolic reprogramming relevant to autoimmunity. Demonstrates untargeted profiling in immunometabolism.